Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug2687 | Questionnaire Administration Wiki | 0.29 |
Name (Synonyms) | Correlation | |
---|---|---|
D002285 | Carcinoma, Intraductal, Noninfiltrating NIH | 1.00 |
D002278 | Carcinoma in Situ NIH | 1.00 |
D044584 | Carcinoma, Ductal NIH | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0030075 | Ductal carcinoma in situ HPO | 1.00 |
HP:0030731 | Carcinoma HPO | 0.50 |
HP:0003002 | Breast carcinoma HPO | 0.45 |
Navigate: Correlations HPO
There is one clinical trial.
A Multi-centre, 18-months, Single-group Study of Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Metabolomic and Laboratory Evaluation of Plasma Therapy Effectiveness.
Description: Death, for any reason
Measure: Death, for any reason Time: 7 days after transfusionDescription: For patients with respiratory support, the time to take one's own breath (extubation)
Measure: For patients with respiratory support, the time to take one's own breath (extubation) Time: 7 days after transfusionDescription: Stay in the intensive care unit (ICU)
Measure: Stay in the intensive care unit (ICU) Time: 7 days after transfusionDescription: Time to disconnect CPAP respiratory support
Measure: Time to disconnect CPAP respiratory support Time: 7 days after transfusionDescription: Time to elimination of SARS-Cov-2 (RT-PCR)
Measure: Time to elimination of SARS-Cov-2 (RT-PCR) Time: 7 days after transfusionDescription: Time to serological response (anti-SARS-COv-2 antibodies)
Measure: Time to serological response (anti-SARS-COv-2 antibodies) Time: 7 days after transfusionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports